| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.36 | 7e-07 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |